DE68905161D1 - Den blutcholesterinspiegel senkende arzneimittel. - Google Patents
Den blutcholesterinspiegel senkende arzneimittel.Info
- Publication number
- DE68905161D1 DE68905161D1 DE8989312031T DE68905161T DE68905161D1 DE 68905161 D1 DE68905161 D1 DE 68905161D1 DE 8989312031 T DE8989312031 T DE 8989312031T DE 68905161 T DE68905161 T DE 68905161T DE 68905161 D1 DE68905161 D1 DE 68905161D1
- Authority
- DE
- Germany
- Prior art keywords
- lowing
- medicines
- cholesterol level
- blood cholesterol
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/274,173 US4997658A (en) | 1988-11-21 | 1988-11-21 | Method for enhancing the lowering of plasma cholesterol levels |
Publications (2)
Publication Number | Publication Date |
---|---|
DE68905161D1 true DE68905161D1 (de) | 1993-04-08 |
DE68905161T2 DE68905161T2 (de) | 1993-08-26 |
Family
ID=23047096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8989312031T Expired - Fee Related DE68905161T2 (de) | 1988-11-21 | 1989-11-20 | Den blutcholesterinspiegel senkende arzneimittel. |
Country Status (6)
Country | Link |
---|---|
US (1) | US4997658A (de) |
EP (1) | EP0375156B1 (de) |
JP (1) | JPH0699327B2 (de) |
CA (1) | CA2003385A1 (de) |
DE (1) | DE68905161T2 (de) |
LV (1) | LV5785B4 (de) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5225202A (en) * | 1991-09-30 | 1993-07-06 | E. R. Squibb & Sons, Inc. | Enteric coated pharmaceutical compositions |
HU217629B (hu) * | 1991-12-12 | 2000-03-28 | Novartis Ag. | Eljárás fluvasztatint tartalmazó stabilizált gyógyszerkészítmények előállítására |
US6818229B1 (en) | 1993-09-20 | 2004-11-16 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia |
US6080428A (en) | 1993-09-20 | 2000-06-27 | Bova; David J. | Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
US6129930A (en) | 1993-09-20 | 2000-10-10 | Bova; David J. | Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night |
US6746691B2 (en) | 1993-09-20 | 2004-06-08 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics |
US6676967B1 (en) * | 1993-09-20 | 2004-01-13 | Kos Pharmaceuticals, Inc. | Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia |
US20060263428A1 (en) * | 1993-09-20 | 2006-11-23 | Eugenio Cefali | Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics |
EP0807435A3 (de) * | 1996-05-17 | 1999-02-24 | Sertürner Arzneimittel GmbH | Indirekter HMG-CoA-Reduktase-Hemmer |
SE9603667D0 (sv) * | 1996-10-08 | 1996-10-08 | Astra Ab | Pharmaceutical compositions |
KR100213895B1 (ko) * | 1996-10-14 | 1999-08-02 | 박원훈 | 감귤류 과피 추출물, 이로부터 분리 정제된 헤스페리딘 또는 나린진을 포함하는 심혈관 질환 예방및 치료제 조성물 |
US20060141036A1 (en) * | 1997-12-12 | 2006-06-29 | Andrx Labs Llc | HMG-CoA reductase inhibitor extended release formulation |
US20040029962A1 (en) * | 1997-12-12 | 2004-02-12 | Chih-Ming Chen | HMG-COA reductase inhibitor extended release formulation |
AU5758799A (en) * | 1998-09-25 | 2000-04-17 | Sankyo Company Limited | Hmg-coa reductase inhibitor-containing preparations |
US20020169145A1 (en) * | 1998-10-14 | 2002-11-14 | Rajen Shah | Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
US6569461B1 (en) * | 1999-03-08 | 2003-05-27 | Merck & Co., Inc. | Dihydroxy open-acid and salts of HMG-CoA reductase inhibitors |
NZ518822A (en) * | 1999-11-04 | 2004-12-24 | Andrx Corp | Treating a mammal with an APP processing disorder such as Alzheimer's Disease and Down's Syndrome by administering at least one HMG-CoA reductase inhibitor |
US20020107173A1 (en) * | 1999-11-04 | 2002-08-08 | Lawrence Friedhoff | Method of treating amyloid beta precursor disorders |
US6242003B1 (en) | 2000-04-13 | 2001-06-05 | Novartis Ag | Organic compounds |
US20060127474A1 (en) * | 2001-04-11 | 2006-06-15 | Oskar Kalb | Pharmaceutical compositions comprising fluvastatin |
WO2003000239A1 (en) * | 2001-06-21 | 2003-01-03 | Andrx Pharmaceuticals, Inc. | Stable pharmaceutical compositions containing pravastatin |
US20040180087A1 (en) * | 2001-06-21 | 2004-09-16 | Boyong Li | Stable controlled release pharmaceutical compositions containing pravastatin |
US20040186089A1 (en) * | 2001-11-08 | 2004-09-23 | Scolnick Edward M. | Compounds useful in the treatment of anthrax |
EP1905431A1 (de) * | 2002-01-11 | 2008-04-02 | Circ Pharma Research and Development Limited | Pharmazeutische Pravastatin-Formulierungen und Verfahren zu ihrer Verwendung |
US6967218B2 (en) * | 2002-01-11 | 2005-11-22 | Biovail Laboratories, Inc. | Pravastatin pharmaceutical formulations and methods of their use |
WO2004021973A2 (en) * | 2002-09-03 | 2004-03-18 | Biovail Laboratories Inc. | Pravastatin pharmaceutical formulations and methods of their use |
SI21400A (sl) * | 2003-02-12 | 2004-08-31 | LEK farmacevtska družba d.d. | Stabilna farmacevtska oblika z inhibitorjem HMG-CoA reduktaze |
CA2568542A1 (en) * | 2004-05-27 | 2005-12-08 | Dexcel Pharma Technologies Ltd. | Localized controlled absorption of statins in the gastrointestinal tract for achieving high blood levels of statins |
US20090196889A1 (en) * | 2004-11-22 | 2009-08-06 | Dexcel Pharma Technologies Ltd. | Controlled absorption of statins in the intestine |
EP1863449A2 (de) * | 2005-03-28 | 2007-12-12 | Dexcel Pharma Technologies Ltd. | Kontrollierte resorption von statinen im darm |
EP2079448A2 (de) * | 2006-10-10 | 2009-07-22 | Dexcel Pharma Technologies Ltd. | Verbesserte freisetzung von statinen im darm |
KR100836960B1 (ko) | 2007-09-07 | 2008-06-10 | 주식회사 서울제약 | 새로운 나이아신 제어방출형 제제 |
EP3698797A1 (de) | 2017-10-16 | 2020-08-26 | Tsinghua University | -inhibitor des mevalonsäurewegs und pharmazeutische zusammensetzung davon |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3538214A (en) * | 1969-04-22 | 1970-11-03 | Merck & Co Inc | Controlled release medicinal tablets |
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4256108A (en) * | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
US4160452A (en) * | 1977-04-07 | 1979-07-10 | Alza Corporation | Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina |
US4200098A (en) * | 1978-10-23 | 1980-04-29 | Alza Corporation | Osmotic system with distribution zone for dispensing beneficial agent |
US4285987A (en) * | 1978-10-23 | 1981-08-25 | Alza Corporation | Process for manufacturing device with dispersion zone |
US4327725A (en) * | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
US4612008A (en) * | 1983-05-11 | 1986-09-16 | Alza Corporation | Osmotic device with dual thermodynamic activity |
US4755180A (en) * | 1986-06-16 | 1988-07-05 | Alza Corporation | Dosage form comprising solubility regulating member |
ZA874487B (en) * | 1986-06-23 | 1987-12-23 | Merck & Co.,Inc. | Novel hmg-coa reductase inhibitors |
CA1331563C (en) * | 1987-08-03 | 1994-08-23 | Gaylen M. Zentner | Device for the controlled release of drugs with donnan-like modulation by charged insoluble resins |
US4900754A (en) * | 1987-12-21 | 1990-02-13 | Rorer Pharmaceutical Corp. | HMG-COA reductase inhibitors |
US4892884A (en) * | 1987-12-21 | 1990-01-09 | Rorer Pharmaceutical Corporation | Novel hmg-coa reductase inhibitors |
US4863957A (en) * | 1987-12-21 | 1989-09-05 | Rorer Pharmaceutical Corporation | Novel HMG-CoA reductase inhibitors |
-
1988
- 1988-11-21 US US07/274,173 patent/US4997658A/en not_active Expired - Lifetime
-
1989
- 1989-11-20 CA CA002003385A patent/CA2003385A1/en not_active Abandoned
- 1989-11-20 DE DE8989312031T patent/DE68905161T2/de not_active Expired - Fee Related
- 1989-11-20 EP EP89312031A patent/EP0375156B1/de not_active Expired - Lifetime
- 1989-11-21 JP JP1303009A patent/JPH0699327B2/ja not_active Expired - Fee Related
-
1996
- 1996-07-22 LV LV960292A patent/LV5785B4/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2003385A1 (en) | 1990-05-21 |
DE68905161T2 (de) | 1993-08-26 |
JPH02237937A (ja) | 1990-09-20 |
EP0375156A3 (en) | 1990-12-12 |
JPH0699327B2 (ja) | 1994-12-07 |
LV5785A4 (lv) | 1997-02-20 |
EP0375156A2 (de) | 1990-06-27 |
EP0375156B1 (de) | 1993-03-03 |
US4997658A (en) | 1991-03-05 |
LV5785B4 (lv) | 1997-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68905161D1 (de) | Den blutcholesterinspiegel senkende arzneimittel. | |
DE68905249T2 (de) | Blutbehaelter. | |
DE69018647D1 (de) | Arzneimittel. | |
DE3783437D1 (de) | Heilmittel. | |
NO901158L (no) | Blodtrykk-overvaakningskateter. | |
DE3871735T2 (de) | Blutfilter. | |
DE68917895D1 (de) | Katheter. | |
DE68924604D1 (de) | Kanüleneinsteckteil. | |
FI875326A (fi) | Ljusbestraolningsanordning foer medicinal vaord av oera. | |
FI881177A0 (fi) | Anordning foer positionering av en patient i en medicinsk panoramaroentgenfotograferingsanordning. | |
FI914213A0 (fi) | Anordning foer foerflyttande av patient. | |
DE68920797D1 (de) | Herzmittel. | |
FI884048A0 (fi) | Foerfarande foer bestaemning av halten av en gaskomponent i en patients andningsluft. | |
DE3784595T2 (de) | Arzneimittel gegen feste tumoren. | |
FI905236A0 (fi) | Deoxiribonukleosider innehaollande farmaceutiska konsistenser foer laekning av saor. | |
FI896174A0 (fi) | Spektriskt effektivt foerfarande foer foermedlande av den informationssignal. | |
FI875616A0 (fi) | Farmaceutiska blandningar. | |
DE363229T1 (de) | Sphygmomanometer. | |
DE3878494D1 (de) | Mittel gegen zuckerkrankheit. | |
FI912644A0 (fi) | Antimikrobiskt medel. | |
IT1229015B (it) | Tomografia. | |
DE3887237D1 (de) | Arzneimittel. | |
ATE100315T1 (de) | Arzneimittel. | |
FI891231A0 (fi) | Anordning foer foerflyttning av patient. | |
FI892374A0 (fi) | Anordning foer foerflyttning av patient. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |